Eugene

[email protected]

LATEST

Batavia Biosciences in Vaccine Manufacturing Pact
By

By
Batavia Biosciences, a technology services provider, has partnered with an international consortium coordinated by PATH, a non-profit organization focused on global health, to develop and manufacture oral poliovirus vaccines (nOPV).…

AstraZeneca, Cambrex in Intermediate Supply Pact
By

By
AstraZeneca and Cambrex, a contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), have formed a long-term manufacturing agreement under which Cambrex is supplying an intermediate. The companies made the announcement…

Merck & Co., AstraZeneca, and Roche Lead Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Roche, Merck & Co., AstraZeneca, and Shire. Editor’s Note: This article was updated on a continuous…

Gene Therapy Catapult, CombiGene in Gene Therapy Mfg Pact
By

By
Cell and Gene Therapy (CGT) Catapult, a center of excellence funded by Innovate UK, the UK government’s innovation agency, to support cell- therapy organizations, and CombiGene, a Lund, Sweden-headquartered biopharmaceutical…

Sartorius Stedim Biotech Partners for T Cell-Activation Product
By

By
Sartorius Stedim Biotech, a supplier for the biopharmaceutical industry, has signed a pact with Quad Technologies, a Woburn, Massachusetts-based biotechnology company that specializes in cell- separation technologies. This partnership is…

AGC Biologics Launches as New Branded Entity
By

By
Asahi Glass Company Bioscience, part of Asahi Glass Company, a Tokyo-headquartered glass and chemical producer, Biomeva GmbH, a Heidelberg, Germany-based contract manufacturing organization, and CMC Biologics, a Bothell, Washington-based contract…

Aviragen, Vaxart To Merge to Form Oral Vaccines Company
By

By
Aviragen Therapeutics, an Alpharetta, Georgia-headquartered pharmaceutical company, and Vaxart, a South San Francisco, California-headquartered developer of oral recombinant vaccines, plan to merge, in deal first proposed in October 2017. Based…

Athenex To Build $200-Million Mfg Facility
By

By
Athenex, a Buffalo, New York-headquartered biopharmaceutical company, has signed an agreement with M+W, a Stuttgart, Germany-headquartered construction company, to design and construct a new, approximately 320,000-square-foot pharmaceutical manufacturing facility in…

FDA Notes Fresenius’ Recall of Syringes
By

By
The US Food and Drug Administration (FDA) has classified a voluntary Class I recall from Fresenius Kabi, a Lake Zurich, Illinois-headquartered specialty and generic pharmaceuticals company and a subsidiary of…

Mallinckrodt To Sell Hemostasis Products to Baxter
By

By
Mallinckrodt, a specialty pharmaceutical company, has agreed to sell certain hemostasis products to Baxter International for approximately $185 million, which includes an upfront payment of $153 million, inclusive of existing…